| Post |
| Pre |
| LA |
|---|
| 4.5 |
| 3.5 |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 1 | - | - | - | - | - | - | - | 1 |
| 1 | 3 | - | - | - | - | - | - | - | - | 4 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 161 | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 40.5 |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 300 |
| 2.5 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PLP(L) | 372 | 27.3% | -8.54 | 1 | 4.2% |
| Optic-unspecified(L) | 349 | 25.6% | -5.45 | 8 | 33.3% |
| LO(L) | 322 | 23.6% | -inf | 0 | 0.0% |
| CentralBrain-unspecified | 228 | 16.7% | -5.83 | 4 | 16.7% |
| AME(L) | 81 | 5.9% | -inf | 0 | 0.0% |
| LA(L) | 9 | 0.7% | -0.36 | 7 | 29.2% |
| ME(L) | 1 | 0.1% | 2.00 | 4 | 16.7% |
| upstream partner | # | NT | conns Lat2 | % In | CV |
|---|---|---|---|---|---|
| aMe1 (L) | 2 | GABA | 83.5 | 12.7% | 0.2 |
| MeVP11 (L) | 23 | ACh | 66.5 | 10.1% | 0.8 |
| MeLo1 (L) | 24 | ACh | 49 | 7.4% | 0.9 |
| MeVP38 (L) | 1 | ACh | 28.5 | 4.3% | 0.0 |
| MeVC20 (L) | 2 | Glu | 26.5 | 4.0% | 0.1 |
| aMe4 (L) | 9 | ACh | 24 | 3.6% | 0.8 |
| LT43 (L) | 2 | GABA | 21.5 | 3.3% | 0.3 |
| aMe6b (L) | 1 | ACh | 20 | 3.0% | 0.0 |
| MeLo3b (L) | 15 | ACh | 20 | 3.0% | 0.9 |
| DNpe053 (L) | 1 | ACh | 14.5 | 2.2% | 0.0 |
| aMe3 (L) | 1 | Glu | 14 | 2.1% | 0.0 |
| SAD044 (L) | 2 | ACh | 11.5 | 1.7% | 0.1 |
| LC14a-2 (R) | 2 | ACh | 10 | 1.5% | 0.8 |
| 5thsLNv_LNd6 (L) | 2 | ACh | 9.5 | 1.4% | 0.1 |
| TmY17 (L) | 9 | ACh | 9.5 | 1.4% | 1.2 |
| LoVC25 (R) | 6 | ACh | 9.5 | 1.4% | 0.5 |
| LoVP57 (L) | 1 | ACh | 9 | 1.4% | 0.0 |
| LC41 (L) | 3 | ACh | 9 | 1.4% | 0.1 |
| MeVCMe1 (R) | 2 | ACh | 8 | 1.2% | 0.0 |
| Li14 (L) | 9 | Glu | 7 | 1.1% | 0.3 |
| PLP144 (L) | 1 | GABA | 6.5 | 1.0% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 6.5 | 1.0% | 0.0 |
| MeVCMe1 (L) | 2 | ACh | 6.5 | 1.0% | 0.8 |
| MeLo2 (L) | 6 | ACh | 6.5 | 1.0% | 0.7 |
| MeVPMe12 (R) | 2 | ACh | 6 | 0.9% | 0.5 |
| LC14b (R) | 4 | ACh | 6 | 0.9% | 0.4 |
| LoVP72 (L) | 1 | ACh | 5.5 | 0.8% | 0.0 |
| LoVC4 (L) | 1 | GABA | 5 | 0.8% | 0.0 |
| OCG02c (R) | 2 | ACh | 5 | 0.8% | 0.2 |
| Li18b (L) | 6 | GABA | 5 | 0.8% | 0.4 |
| MeVPaMe2 (R) | 1 | Glu | 4.5 | 0.7% | 0.0 |
| LoVC11 (R) | 1 | GABA | 4 | 0.6% | 0.0 |
| LoVP42 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| LC37 (L) | 2 | Glu | 4 | 0.6% | 0.2 |
| LoVCLo3 (L) | 1 | OA | 4 | 0.6% | 0.0 |
| aMe6a (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 3.5 | 0.5% | 0.0 |
| LoVP71 (L) | 1 | ACh | 3.5 | 0.5% | 0.0 |
| LoVP16 (L) | 2 | ACh | 3.5 | 0.5% | 0.7 |
| MeVC22 (L) | 2 | Glu | 3.5 | 0.5% | 0.1 |
| aMe13 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| MeVP31 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| MeVP10 (L) | 3 | ACh | 3 | 0.5% | 0.4 |
| MeVP30 (L) | 1 | ACh | 2.5 | 0.4% | 0.0 |
| MeVP49 (L) | 1 | Glu | 2.5 | 0.4% | 0.0 |
| LT55 (L) | 1 | Glu | 2.5 | 0.4% | 0.0 |
| PLP250 (L) | 1 | GABA | 2.5 | 0.4% | 0.0 |
| AVLP539 (L) | 1 | Glu | 2.5 | 0.4% | 0.0 |
| Li35 (L) | 2 | GABA | 2.5 | 0.4% | 0.2 |
| DNpe053 (R) | 1 | ACh | 2.5 | 0.4% | 0.0 |
| MeVP1 (L) | 3 | ACh | 2.5 | 0.4% | 0.3 |
| Tm37 (L) | 3 | Glu | 2.5 | 0.4% | 0.3 |
| Tm16 (L) | 5 | ACh | 2.5 | 0.4% | 0.0 |
| PLP186 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| SLP386 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| PLP131 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| PLP021 (L) | 2 | ACh | 2 | 0.3% | 0.5 |
| PLP231 (L) | 2 | ACh | 2 | 0.3% | 0.5 |
| PS272 (R) | 2 | ACh | 2 | 0.3% | 0.5 |
| MeVPMe11 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| 5-HTPMPV01 (R) | 1 | 5-HT | 2 | 0.3% | 0.0 |
| Lat3 (L) | 3 | unc | 2 | 0.3% | 0.4 |
| aMe30 (L) | 3 | Glu | 2 | 0.3% | 0.4 |
| LPT53 (L) | 1 | GABA | 1.5 | 0.2% | 0.0 |
| SLP322 (L) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| aMe20 (L) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| MeTu4c (L) | 2 | ACh | 1.5 | 0.2% | 0.3 |
| Cm20 (L) | 2 | GABA | 1.5 | 0.2% | 0.3 |
| LoVP96 (L) | 1 | Glu | 1.5 | 0.2% | 0.0 |
| aMe2 (L) | 1 | Glu | 1.5 | 0.2% | 0.0 |
| aMe10 (R) | 2 | ACh | 1.5 | 0.2% | 0.3 |
| OA-AL2i3 (L) | 1 | OA | 1.5 | 0.2% | 0.0 |
| MeLo6 (L) | 3 | ACh | 1.5 | 0.2% | 0.0 |
| aMe5 (L) | 3 | ACh | 1.5 | 0.2% | 0.0 |
| aMe6c (L) | 2 | Glu | 1.5 | 0.2% | 0.3 |
| MeVC23 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| Lat4 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| MeVPMe3 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP066 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP60 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB0937 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP460 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP149 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LoVP97 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVC21 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| LoVP45 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| aMe17c (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| TmY10 (L) | 2 | ACh | 1 | 0.2% | 0.0 |
| MeVP14 (L) | 2 | ACh | 1 | 0.2% | 0.0 |
| MeVC24 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVP22 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| aMe12 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVP29 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVC22 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| LoVC18 (L) | 2 | DA | 1 | 0.2% | 0.0 |
| LoVP83 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LC10a (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| aMe22 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| LC13 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| AOTU055 (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| MeLo7 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LoVP38 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| Lat2 (L) | 1 | unc | 0.5 | 0.1% | 0.0 |
| SLP249 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| CL356 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LPT60 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LAL047 (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| LoVC19 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| Li31 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| DNp32 (L) | 1 | unc | 0.5 | 0.1% | 0.0 |
| Li20 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| Li23 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVP3 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeLo13 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| Li13 (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| LT52 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| CB3001 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| PLP086 (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| LoVP10 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| OCG02c (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| CL102 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVP62 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| HBeyelet (L) | 1 | HA | 0.5 | 0.1% | 0.0 |
| LoVP50 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVP25 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 0.5 | 0.1% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 0.5 | 0.1% | 0.0 |
| aMe17a (L) | 1 | unc | 0.5 | 0.1% | 0.0 |
| DNp27 (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| downstream partner | # | NT | conns Lat2 | % Out | CV |
|---|---|---|---|---|---|
| Lat4 (L) | 1 | unc | 3.5 | 18.9% | 0.0 |
| aMe3 (L) | 1 | Glu | 2 | 10.8% | 0.0 |
| aMe6c (L) | 2 | Glu | 1.5 | 8.1% | 0.3 |
| MeVP14 (L) | 1 | ACh | 1 | 5.4% | 0.0 |
| aMe4 (L) | 1 | ACh | 1 | 5.4% | 0.0 |
| aMe2 (L) | 2 | Glu | 1 | 5.4% | 0.0 |
| Lat1 (L) | 2 | unc | 1 | 5.4% | 0.0 |
| aMe23 (L) | 1 | Glu | 0.5 | 2.7% | 0.0 |
| Cm4 (L) | 1 | Glu | 0.5 | 2.7% | 0.0 |
| MeVP11 (L) | 1 | ACh | 0.5 | 2.7% | 0.0 |
| LoVP39 (L) | 1 | ACh | 0.5 | 2.7% | 0.0 |
| l-LNv (L) | 1 | unc | 0.5 | 2.7% | 0.0 |
| SMP217 (L) | 1 | Glu | 0.5 | 2.7% | 0.0 |
| Lat3 (L) | 1 | unc | 0.5 | 2.7% | 0.0 |
| MeVP_unclear (L) | 1 | Glu | 0.5 | 2.7% | 0.0 |
| aMe9 (R) | 1 | ACh | 0.5 | 2.7% | 0.0 |
| Lat2 (L) | 1 | unc | 0.5 | 2.7% | 0.0 |
| aMe17b (L) | 1 | GABA | 0.5 | 2.7% | 0.0 |
| LoVP63 (L) | 1 | ACh | 0.5 | 2.7% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.5 | 2.7% | 0.0 |
| aMe15 (L) | 1 | ACh | 0.5 | 2.7% | 0.0 |
| MeVC22 (L) | 1 | Glu | 0.5 | 2.7% | 0.0 |